XellSmart
About:
Xellsmart develops stem cell treatment solutions for a variety of degenerative diseases for which there are now no clinical treatments.
Website: http://www.xellsmart.com
Top Investors: Eli Lilly, Qiming Venture Partners, HongShan, Tao Capital Partners, Oriza Holdings
Description:
Xellsmart develops stem cell treatment solutions for a variety of degenerative diseases for which there are now no clinical treatments. Xellsmart is located in Minhang District, Shanghai, China.
Total Funding Amount:
177M CNY
Headquarters Location:
Minhang, Shanghai, China
Founded Date:
2021-01-01
Contact Email:
hr(AT)xellsmart.com
Founders:
Xiang Li
Number of Employees:
101-250
Last Funding Date:
2024-10-21
IPO Status:
Private
Industries:
© 2025 bioDAO.ai